LIFEVANTAGE CORP (LFVN) Debt Components
- 2020-06-30: Short-term DebtUSD (m); Long-term Debt, Current MaturitiesUSD $0.00; Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD (m).
- 2020-03-31: Short-term DebtUSD (m); Long-term Debt, Current MaturitiesUSD $0.00; Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD (m).
- 2019-12-31: Short-term DebtUSD (m); Long-term Debt, Current MaturitiesUSD $484.00K; Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD (m).
- 2019-09-30: Short-term DebtUSD (m); Long-term Debt, Current MaturitiesUSD $969.00K; Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD (m).
LIFEVANTAGE CORP Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Short-term Debt USD | Long-term Debt, Current Maturities USD | Long-term Debt, Excluding Current Maturities USD | Long-term Debt USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Year Four USD | Long-Term Debt, Maturity, Year Five USD | Long-Term Debt, Maturity, after Year Five USD | Long-Term Debt, Maturity, Remainder of Fiscal Year USD | Long-term Debt, Gross USD | Debt, Long-term and Short-term, Combined Amount USD | Debt Instrument, Unamortized Discount USD | Debt Instrument, Convertible, Interest Expense (Deprecated 2013-01-31) USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020-06-30 | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | $484.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | (m) | $969.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | $1.45M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | $0.00 | (m) |
| 2019-03-31 | (m) | $1.94M | $0.00 | (m) | (m) | $1.50M | (m) | (m) | (m) | (m) | $500.00K | $0.00 | $2.00M | $0.00 | (m) |
| 2018-12-31 | (m) | $2.00M | $2.43M | (m) | (m) | $2.00M | $1.50M | (m) | (m) | (m) | $1.00M | $2.50M | $4.50M | $73.00K | (m) |
| 2018-09-30 | (m) | $2.00M | $2.92M | (m) | (m) | $2.00M | $1.50M | (m) | (m) | (m) | $1.50M | $3.00M | $5.00M | $79.00K | (m) |
| 2018-06-30 | (m) | $2.00M | $3.41M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $3.50M | (m) | $88.00K | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) | $2.00M | $2.00M | $1.50M | (m) | (m) | (m) | (m) | (m) | $5.50M | (m) | (m) |
| 2018-03-31 | (m) | $2.00M | $3.96M | (m) | (m) | $2.00M | $2.00M | $1.50M | (m) | (m) | $500.00K | $4.00M | $6.00M | $35.00K | (m) |
| 2017-12-31 | (m) | $2.00M | $4.46M | (m) | (m) | $5.50M | (m) | (m) | (m) | (m) | $1.00M | $4.50M | $6.50M | $43.00K | (m) |
| 2017-09-30 | (m) | $2.00M | $4.95M | (m) | (m) | $5.50M | (m) | (m) | (m) | (m) | $1.50M | $5.00M | $7.00M | $52.00K | (m) |
| 2017-06-30 | (m) | $2.00M | $5.44M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $5.50M | (m) | $60.00K | (m) |
| 2017-06-30 | (m) | (m) | (m) | (m) | $2.00M | $5.50M | (m) | (m) | (m) | (m) | (m) | (m) | $7.50M | (m) | (m) |
| 2017-03-31 | (m) | $2.00M | $5.93M | (m) | (m) | $2.00M | $5.50M | (m) | (m) | (m) | $500.00K | $6.00M | $8.00M | $68.00K | (m) |
| 2016-12-31 | (m) | $2.00M | $6.42M | (m) | (m) | $2.00M | $5.50M | (m) | (m) | (m) | $1.00M | $6.50M | $8.50M | $76.00K | (m) |
| 2016-09-30 | (m) | $2.00M | $6.92M | (m) | (m) | $2.00M | $5.50M | (m) | (m) | (m) | $1.50M | $7.00M | $9.00M | $84.00K | (m) |
| 2016-06-30 | (m) | $2.00M | $7.41M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $7.50M | (m) | $91.00K | (m) |
| 2016-06-30 | (m) | (m) | (m) | (m) | $2.00M | $2.00M | $5.50M | (m) | (m) | (m) | (m) | (m) | $9.50M | (m) | (m) |
| 2016-03-31 | (m) | $2.00M | $7.90M | (m) | (m) | $2.00M | $2.00M | $5.50M | (m) | (m) | $500.00K | $8.00M | $10.00M | $99.00K | (m) |
| 2015-12-31 | (m) | $12.23M | $1.04M | (m) | (m) | $7.93M | (m) | (m) | (m) | (m) | $6.88M | $2.58M | $14.81M | $1.54M | (m) |
| 2015-09-30 | (m) | $11.72M | $5.02M | (m) | (m) | $9.46M | (m) | (m) | (m) | (m) | $9.05M | $6.79M | $18.51M | $1.77M | (m) |
| 2015-06-30 | (m) | $11.14M | $8.53M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $10.48M | (m) | $1.95M | (m) |
| 2015-06-30 | (m) | (m) | (m) | (m) | $11.14M | $10.48M | (m) | (m) | (m) | (m) | (m) | (m) | $21.62M | (m) | (m) |
| 2015-03-31 | (m) | $9.20M | $17.20M | (m) | (m) | $4.70M | $4.70M | $4.70M | $7.53M | $0.00 | $5.67M | $18.10M | $27.30M | $905.00K | (m) |
| 2014-12-31 | (m) | $4.70M | $22.82M | (m) | (m) | $4.70M | $4.70M | $4.70M | $12.03M | $0.00 | $2.35M | $23.77M | $28.48M | $955.00K | (m) |
| 2014-09-30 | (m) | $4.70M | $23.95M | (m) | (m) | $4.70M | $4.70M | $4.70M | $12.03M | $0.00 | $3.52M | $24.95M | $29.65M | $1.00M | (m) |
| 2014-06-30 | (m) | $4.70M | $25.07M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $26.12M | (m) | $1.05M | (m) |
| 2014-06-30 | (m) | (m) | (m) | (m) | $4.70M | $4.70M | $4.70M | $4.70M | $4.70M | $7.33M | (m) | (m) | $30.82M | (m) | (m) |
| 2014-03-31 | $4.70M | (m) | (m) | $40.03M | (m) | $4.70M | $4.70M | $4.70M | $4.70M | $25.85M | $1.18M | $41.12M | $45.83M | $1.10M | (m) |
| 2013-12-31 | $4.70M | (m) | (m) | $41.16M | (m) | $4.70M | $4.70M | $4.70M | $4.70M | $25.85M | $2.35M | $42.30M | $47.00M | $1.15M | (m) |
| 2013-06-30 | (m) | $0.00 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | $0.00 | (m) |
| 2013-06-30 | $0.00 | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $1.06M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |